AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2083851
Drug: Terconazole, 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terconazole, 240 mg, one dose per day
Trial: 2083851
Drug: Terconazole, 80
RxNorm normalized name: Terconazole, 80 mg vaginal suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terconazole, 80 mg, daily dose for three days
Trial: 2083851
Drug: Chlotrimazole, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlotrimazole, 200 mg, daily dose for three days
Trial: 6161897
Drug: Macrodex 6%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Macrodex 6% (500 ml Dextran 60 infusion)
Trial: 6161897
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl (500 ml)
Trial: 26011677
Drug: ZS-9 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZS-9 5 g
Trial: 26011677
Drug: ZS-9 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZS-9 15 g
Trial: 17353471
Drug: IV immunoglobulin
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV immunoglobulin (IVIG) 2 g/kg
Trial: 11152366
Drug: 100 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/kg methionine
Trial: 11152366
Drug: 100 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/kg methionine plus 2 g of vitamin C
Trial: 1634718
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of bupivacaine and fentanyl
Trial: 1634718
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of fentanyl
Trial: 30629280
Drug: Intranasal REMOXY
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal REMOXY ER (manipulated or intact)
Trial: 30629280
Drug: Ground oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ground oxycodone IR
Trial: 24211813
Drug: Levofloxacin (LVFX)
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin (LVFX) 500 mg administered orally
Trial: 17237007
Drug: Chemotherapy regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy regimen with 5-fluorouracil and folinic acid (FUFOL)
Trial: 15978775
Drug: Onlay augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onlay augmentation
Trial: 11886484
Drug: E2 +
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: E2 + T (trimegestone 0.5 mg)
Trial: 11886484
Drug: E2 (oestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2 (oestradiol 2 mg)
Trial: 11886484
Drug: E2 +
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: E2 + D (dydrogesterone 10 mg)
Trial: 10460069
Drug: Clomipramine 25
RxNorm normalized name: clomiPRAMINE 25 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine 25 mg/day
Trial: 10460069
Drug: Clomipramine 50
RxNorm normalized name: clomiPRAMINE 50 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine 50 mg/day
Trial: 10460069
Drug: Clomipramine 125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine 125 mg/day
Trial: 10460069
Drug: Clomipramine 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine 200 mg/day
Trial: 10460069
Drug: Clomipramine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (all doses)
Trial: 7798508
Drug: Bisoprolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (10 mg daily)
Trial: 7798508
Drug: Nifedipine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (2 x 20 mg)
Trial: 7798508
Drug: Bisoprolol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (20 mg daily)
Trial: 2074163
Drug: naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: naproxen sodium 550 mg bid
Trial: 2074163
Drug: pizotyline 0.5
RxNorm normalized name: pizotyline 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pizotyline 0.5 mg tid
Trial: 30696533
Drug: Nasal spray
RxNorm normalized name: Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal spray containing silver vitellinate, hyaluronic acid and sodium benzoate
Trial: 30696533
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (sodium chloride 0.9%)
Trial: 28058800
Drug: Negligible carbohydrate
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negligible carbohydrate snacks (up to 5.1 g carbohydrate and 276.3 kJ per portion)
Trial: 25664905
Drug: i.v. ascorbate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ascorbate infusion
Trial: 25664905
Drug: Ascorbate infusion
RxNorm normalized name: ascorbate
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbate infusion plus oral H1/H2 histamine receptor blockade
Trial: 25664905
Drug: i.v. N-acetylcysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. N-acetylcysteine infusion
Trial: 25091379
Drug: EPA+DHA supplementation
RxNorm normalized name: eicosapentaenoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA+DHA supplementation (0, 300, 600, 900, or 1,800 mg/d)
Trial: 18922525
Drug: Intravenous salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous salbutamol (0.1 mg bolus with further boluses every 5 minutes as required)
Trial: 11487483
Drug: Standard-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose intravenous immunoglobulin (adults: 300 mg/kg every 4 weeks; children: 400 mg/kg every 4 weeks)
Trial: 11487483
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous immunoglobulin (adults: 600 mg/kg every 4 weeks; children: 800 mg/kg every 4 weeks)
Trial: 11487483
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous immunoglobulin
Trial: 11487483
Drug: Standard-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose intravenous immunoglobulin
Trial: 8110553
Drug: Diamorphine-bupivacaine mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diamorphine-bupivacaine mixture (0.0625% plain bupivacaine 6.25 mg h‐1 mixed with 0.005% diamorphine 0.5 mg h‐1)
Trial: 8110553
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (0.125% plain bupivacaine 12.5 mg h‐1)
Trial: 3074294
Drug: Insulin Protaphane
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin Protaphane HM in Penfill
Trial: 23212859
Drug: Early start
RxNorm normalized name: Star Anise Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early start dialysis (eGFR 10 ‐ 14 mL/min/1.73 m²)
Trial: 23212859
Drug: Late start
RxNorm normalized name: Star Anise Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late start dialysis (eGFR 5 ‐ 7 mL/min/1.73 m²)
Trial: 12176787
Drug: 3-week schedule
RxNorm normalized name: etonogestrel
DrugBank: Etonogestrel (DB00294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-week schedule of gemcitabine (1000 mg/m2 on days 1 and 8 of a 21-day cycle)
Trial: 12176787
Drug: 4-week schedule
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week schedule of gemcitabine (1000 mg/m2 on days 1, 8 and 15 of a 28-day cycle)
Trial: 10210549
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with paclitaxel plus carboplatin
Trial: 2203255
Drug: 90 mL
RxNorm normalized name: 190 ML Infugem 10 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mL tap water ingested over 10 min
Trial: 2203255
Drug: 90 mL
RxNorm normalized name: 190 ML Infugem 10 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mL tap water ingested over 30 min
Trial: 2203255
Drug: 600 mL
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mL tap water ingested over 10 min
Trial: 2203255
Drug: 600 mL
RxNorm normalized name: urinary bag 600 mL-10" MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mL tap water ingested over 30 min
Trial: 30096704
Drug: pembrolizumab 10
RxNorm normalized name: pembrolizumab 100 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pembrolizumab 10 mg/kg every 2 or 3 weeks for 24 months
Trial: 30096704
Drug: ipilimumab 3
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: ipilimumab 3 mg/kg every 3 weeks for four doses
Trial: 26823338
Drug: Measles-Rubella Vaccine
RxNorm normalized name: Rubella virus vaccine
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measles-Rubella Vaccine + Human Rotavirus Vaccine (MR + HRV)
Trial: 26823338
Drug: Measles-Rubella Vaccine
RxNorm normalized name: Rubella virus vaccine
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measles-Rubella Vaccine (MR)
Trial: 22770867
Drug: Nasal gel
RxNorm normalized name: Nasal Gel
DrugBank: Oxymetazoline (DB00935)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nasal gel administered using a radial-hole inhaler
Trial: 22770867
Drug: Different administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different administration methods
Trial: 19913325
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with carboplatin (AUC=5) and docetaxel (75mg/m2) every 3 weeks for four cycles, initiated 1-4 weeks post-surgery, with prophylactic G-CSF supportive therapy.
Trial: 11978748
Drug: Oligosaccharide supplemented
RxNorm normalized name: chitosan oligosaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oligosaccharide supplemented formula (10 g/l)
Trial: 9988877
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of vitamin A (50,000 IU per day, median; range 10,000-300,000 IU per day)
Trial: 9988877
Drug: Nonteratogenic agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonteratogenic agent exposures (control group 2)
Trial: 7787131
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg dose of 14C-FOX 988 (gelatin capsules) with a meal (50% fat by calories) immediately following dosing
Trial: 7787131
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg dose of 14C-FOX 988 (gelatin capsules) with a meal (50% fat by calories) at 2 h post-dose
Trial: 7787131
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg dose of 14C-FOX 988 (suspension, 0.5% CMC) with a meal (50% fat by calories) immediately following dosing
Trial: 7787131
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg dose of 14C-FOX 988 (suspension, 0.5% CMC) with a meal (50% fat by calories) at 2 h post-dose
Trial: 7787131
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg dose of 14C-FOX 988 (gelatin capsules)
Trial: 7787131
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg dose of 14C-FOX 988 (suspension, 0.5% CMC)
Trial: 25830381
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol 50/25 mcg
Trial: 25830381
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol 100/25 mcg
Trial: 25830381
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol 200/25 mcg
Trial: 21378714
Drug: Cytoflavine preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoflavine preparation as energy-correction and antioxidant
Trial: 21378714
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cytoflavine with calcium-D3
Trial: 17594775
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg/calcium-placebo
Trial: 17594775
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg/elemental calcium 1000 mg
Trial: 17594775
Drug: Alendronate-containing treatments
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate-containing treatments
Trial: 17594775
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg with calcium 1000 mg
Trial: 12044254
Drug: Rapid‐acting anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid‐acting anesthetic agents (midazolam, propofol) for refractory status epilepticus
Trial: 2667336
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg before meals
Trial: 973984
Drug: Rifampicin and
RxNorm normalized name: rifampicin and isoniazid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin and Isoniazid in combination
Trial: 22105039
Drug: Lady 4
RxNorm normalized name: Lady's Thistle Seed
DrugBank: Milk thistle (DB14375)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lady 4 (2 capsules daily)
Trial: 19568738
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (n = 17)
Trial: 19568738
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment (n = 15)
Trial: 14744726
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori treatment (omeprazole, amoxicillin, clarythromycin; n = 122)
Trial: 14744726
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori treatment (omeprazole, amoxicillin, clarythromycin)
Trial: 11698315
Drug: i.v. dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. dexamethasone 5 mg
Trial: 3591496
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (career development training sessions)
Trial: 30153988
Drug: Post-procedure bivalirudin
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-procedure bivalirudin infusion
Trial: 28358599
Drug: Azithromycin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (10 mg/kg up to 500 mg per day for 4 weeks)
Trial: 26237812
Drug: Omnic (tamsulosin)
RxNorm normalized name: Omni Gel
DrugBank: Tamsulosin (DB00706)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omnic (tamsulosin) 0.4 mg once daily for 8 years
Trial: 26237812
Drug: Herbal preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal preparations (Gentos, Tadenan, or Speman)
Trial: 21418799
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg/benazepril 10 mg once-daily (combination therapy)
Trial: 21418799
Drug: Benazepril 10
RxNorm normalized name: benazepril 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benazepril 10 mg monotherapy
Trial: 14756429
Drug: Neo-adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neo-adjuvant chemotherapy (3 cycles of CEF before and 3 cycles after surgery)
Trial: 14756429
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (6 cycles of CEF after primary surgery)
Trial: 28816026
Drug: 2000-mg sustained-release
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000-mg sustained-release (SR) acetaminophen
Trial: 28816026
Drug: 1500-mg sustained-release
RxNorm normalized name: SR 121463
DrugBank: SR 121463 (DB05455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500-mg sustained-release (SR) acetaminophen
Trial: 22949381
Drug: Hair zinc
RxNorm normalized name: cat hair extract
DrugBank: Felis catus hair (DB10499)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hair zinc levels in RW group (162.43 ± 91.52 µg/g)
Trial: 22949381
Drug: Hair selenium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hair selenium levels in RW group (217.37 ± 83.01 µg/g)
Trial: 22949381
Drug: Total antioxidant
RxNorm normalized name: Ascorbic Acid/Coenzyme Q10/Grape Seed Extract/Green Tea Extract/Lutein/Lycopene/Selenium/Thioctic Acid/Tocotrienol/Turmeric Extract/Vitamin A/Vitamin E 60 MG-5 MG-10 MG-10 MG-3 MG-1.5 MG-0.1 MG-7.5 MG-5 MG-15 MG-5000 IU-75 IU Oral Capsule, Liquid Filled [TOTAL ANTIOXIDANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total antioxidant capacity (TAC) in RW group (1.38 ± 0.14 mmol/L)
Trial: 21090334
Drug: Medication (metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (metformin 250 mg t.i.d. for 1 week, then 500 mg t.i.d. for 6 months)
Trial: 21090334
Drug: Medication (metformin)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (metformin)
Trial: 18661264
Drug: 0.5% levofloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% levofloxacin (LVFX) ophthalmic solution applied for 3 days with diluted PI eyewash
Trial: 18661264
Drug: 0.5% levofloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% levofloxacin (LVFX) ophthalmic solution applied for 1 day with diluted PI eyewash
Trial: 18661264
Drug: 0.5% levofloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% levofloxacin (LVFX) ophthalmic solution applied for 1 hour with diluted PI eyewash
Trial: 15897530
Drug: Rifaximin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin (200 mg/d, 200 mg twice daily, or 200 mg 3 times daily)
Trial: 10818278
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg ipsapirone
Trial: 6635439
Drug: Parenteral nafcillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nafcillin plus oral rifampin
Trial: 6635439
Drug: Parenteral nafcillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nafcillin alone
Trial: 6635439
Drug: Rifampin in
RxNorm normalized name: rifampin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin in combination with other oral antibiotics
Trial: 30569662
Drug: Sanhuang Xiexin
RxNorm normalized name: MENTHOL 4.3 g / METHYL SALICYLATE 9.4 g TOPICAL OIL [Shuang Long Pain Relieving Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sanhuang Xiexin decoction + basic treatment (SX group)
Trial: 30569662
Drug: basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: basic treatment (control group)
Trial: 28650204
Drug: XEN-D0501 (oral,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XEN-D0501 (oral, 4 mg twice daily)
Trial: 25905795
Drug: Meningococcal B
RxNorm normalized name: MENINGOCOCCAL B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meningococcal B outer membrane vesicle vaccine
Trial: 19767576
Drug: Tannic acid
RxNorm normalized name: Tannic Acid
DrugBank: Tannic acid (DB09372)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tannic acid (TA) treatment (10% and 20%)
Trial: 19767576
Drug: Tannic acid
RxNorm normalized name: Tannic Acid
DrugBank: Tannic acid (DB09372)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tannic acid (TA) treatment
Trial: 1828204
Drug: Thymopentin (continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymopentin (continued treatment during phase II)
Trial: 19852289
Drug: Metformin (WM1)
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (WM1)
Trial: 17885221
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment with early motion controlled in a removable orthosis, progressing to full weightbearing at 8 weeks.
Trial: 17885221
Drug: Nonsurgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsurgical treatment with early motion controlled in a removable orthosis, progressing to full weightbearing at 8 weeks.
Trial: 16366764
Drug: Lorazepam (1.0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (1.0, 2.0 mg/70 kg, oral)
Trial: 16366764
Drug: Scopolamine (0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine (0.3, 0.6 mg/70 kg, subcutaneous)
Trial: 11898005
Drug: 0.1% hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% hydrocortisone butyrate ointment
Trial: 7297433
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of magaldrate administered every two hours